North America Pharma Cloud Services Market

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis

2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis

2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources

2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach

2.4.2.2. Advantages of Primary Research

2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions

2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers

2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity

2.4.3. Analytical Tools and Databases

2.5. Robust Quality Control

3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach

3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)

3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis

3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact

3.6. Limitations

4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
4.2.2.3. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt

4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market

4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics

4.3. Conclusion

5. EXECUTIVE SUMMARY

6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Cloud Computing
6.2.1. Types of Clouds and Cloud Services
6.2.2. Cloud Computing in Drug Discovery, Development and Manufacturing
6.2.3. Benefits and Limitations of Cloud Computing

6.3. Concluding Remarks

7. MARKET LANDSCAPE
7.1. Chapter Overview
7.2. North American Cloud Service Providers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters (Region)
7.2.4. Analysis by Location of Headquarters (Country)
7.2.5. Analysis by Type of Company
7.2.6. Analysis by Cloud Service Business Model
7.2.7. Analysis by Quality Certifications
7.2.8. Analysis by Type of Cloud
7.2.9. Analysis by Type of Cloud Services
7.2.10. Analysis by Area of Application
7.2.11. Analysis by Additional Capabilities
7.2.12. Analysis by Additional Services Offered

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Overview of Peer Groups
8.5. Company Competitiveness Analysis

9. COMPANY PROFILES: PHARMA CLOUD SERVICE PROVIDERS
9.1. Chapter Overview
9.2. Microsoft
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service Portfolio
9.2.4. Recent Developments and Future Outlook

9.3. Google
9.4. Amazon Web Services
9.5. IBM
9.6. Nutanix
9.7. Hewlett Packard Enterprise

10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models

10.3. North America Cloud Service Providers: Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Focus Area
10.3.5. Most Active Players: Analysis by Number of Partnerships

10.3.6. Analysis by Geography
10.3.6.1. Local and International Agreements
10.3.6.2. Intracontinental and Intercontinental Agreements

11. COST SAVING ANALYSIS
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.2.1. Overall Cost Saving Potential of Cloud-based Solutions for Drug Discovery, Development and Manufacturing, till 2035

11.3. Likely Cost Savings in Drug Discovery, till 2035
11.3.1. Likely Cost Savings in Drug Discovery in North America, till 2035
11.3.2. Likely Cost Savings in Drug Discovery in Europe, till 2035
11.3.3. Likely Cost Savings in Drug Discovery in Asia-Pacific, till 2035
11.3.4. Likely Cost Savings in Drug Discovery in Middle East and North Africa, till 2035
11.3.5. Likely Cost Savings in Drug Discovery in Latin America, till 2035
11.3.6. Likely Cost Savings in Drug Discovery in Rest of the World, till 2035

11.4. Likely Cost Savings in Drug Development, till 2035
11.4.1. Likely Cost Savings in Drug Development in North America, till 2035
11.4.2. Likely Cost Savings in Drug Development in Europe, till 2035
11.4.3. Likely Cost Savings in Drug Development in Asia-Pacific, till 2035
11.4.4. Likely Cost Savings in Drug Development in Middle East and North Africa, till 2035
11.4.5. Likely Cost Savings in Drug Development in Latin America, till 2035
11.4.6. Likely Cost Savings in Drug Development in Rest of the World, till 2035

11.5. Likely Cost Savings in Drug Manufacturing, till 2035
11.5.1. Likely Cost Savings in Drug Manufacturing in North America, till 2035
11.5.2. Likely Cost Savings in Drug Manufacturing in Europe, till 2035
11.5.3. Likely Cost Savings in Drug Manufacturing in Asia-Pacific, till 2035
11.5.4. Likely Cost Savings in Drug Manufacturing in Middle East and North Africa, till 2035
11.5.5. Likely Cost Savings in Drug Manufacturing in Latin America, till 2035
11.5.6. Likely Cost Savings in Drug Manufacturing in Rest of the World, till 2035

11.6. Concluding Remarks: Cost Saving Scenarios

12. ANTICIPATED TECHNOLOGY UPGRADES AFFILIATED OPPORTUNITIES
12.1. Chapter Overview
12.2. Key Assumptions and Methodology

12.3. Key Tools and Technologies
12.3.1. Artificial Intelligence
12.3.1.1. Artificial Intelligence in Pharmaceutical Product Development and Manufacturing
12.3.1.2. Likely Cost-Savings by Integrating Artificial Intelligence with Cloud Computing

12.3.2. Deep Learning
12.3.2.1. Deep Learning in Pharmaceutical Product Development and Manufacturing
12.3.2.2. Likely Cost-Savings by Integrating Deep Learning with Cloud Computing

12.3.3. Machine Learning
12.3.3.1. Machine Learning in Pharmaceutical Product Development and Manufacturing
12.3.3.2. Likely Cost-Savings by Integrating Machine Learning with Cloud Computing

12.3.4. Quantum Computing
12.3.4.1. Quantum Computing in Pharmaceutical Product Development and Manufacturing
12.3.4.2. Likely Cost-Savings by Integrating Quantum Computing with Cloud Computing

12.4. Extent of Innovation versus Associated Risk Analysis
12.4.1. Results and Discussion

13. MARKET IMPACT ANALYSIS
13.1. Chapter Overview
13.2. Market Drivers
13.3. Market Restraints
13.4. Market Opportunities
13.5. Market Challenges
13.6. Conclusion

14. NORTH AMERICA CLOUD SERVICES MARKET
14.1. Chapter Overview
14.2. Key Assumptions and Methodology

14.3. North America Pharma Cloud Services Market, Historical Trends (since 2021) and Forecasted Estimates (till 2035)
14.3.1. Roots Analysis Perspective on Market Growth

14.3.2. Scenario Analysis
14.3.2.1. Conservative Scenario
14.3.2.2. Optimistic Scenario

14.4. Key Market Segmentations

15. NORTH AMERICA CLOUD SERVICES MARKET, BY AREA OF APPLICATION
15.1. Chapter Overview
15.2. Key Assumptions and Methodology

15.3. North America Pharma Cloud Services Market: Distribution by Area of Application
15.3.1. North America Pharma Cloud Services Market for Drug Discovery, Historical Trends (since 2021) and Forecasted Estimates (till 2035)
15.3.2. North America Pharma Cloud Services Market for Drug Development, Historical Trends (since 2021) and Forecasted Estimates (till 2035)
15.3.3. North America Pharma Cloud Services Market for Drug Manufacturing, Historical Trends (since 2021) and Forecasted Estimates (till 2035)

15.4. Data Triangulation and Validation

16. NORTH AMERICA CLOUD SERVICES MARKET, BY TYPE OF CLOUD SERVICE
16.1. Chapter Overview
16.2. Key Assumptions and Methodology

16.3. North America Pharma Cloud Services Market: Distribution by Type of Cloud Service
16.3.1. North America Pharma Cloud Services Market for Software as a Service (SaaS), Historical Trends (since 2021) and Forecasted Estimates (till 2035)
16.3.2. North America Pharma Cloud Services Market for Infrastructure as a Service (IaaS), Historical Trends (since 2021) and Forecasted Estimates (till 2035)
16.3.3. North America Pharma Cloud Services Market for Platform as a Service (PaaS), Historical Trends (since 2021) and Forecasted Estimates (till 2035)
16.3.4. North America Pharma Cloud Services Market for Others, Historical Trends (since 2021) and Forecasted Estimate, (till 2035)

16.4. Data Triangulation and Validation

17. NORTH AMERICA CLOUD SERVICES MARKET, BY TYPE OF CLOUD
17.1. Chapter Overview
17.2. Key Assumptions and Methodology

17.3. North America Pharma Cloud Services Market: Distribution by Type of Cloud
17.3.1. North America Pharma Cloud Services Market for Hybrid Cloud, Historical Trends (since 2021) and Forecasted Estimates (till 2035)
17.3.2. North America Pharma Cloud Services Market for Public Cloud, Historical Trends (since 2021) and Forecasted Estimates (till 2035)
17.3.3. North America Pharma Cloud Services Market for Private Cloud, Historical Trends (since 2021) and Forecasted Estimates (till 2035)

17.4. Data Triangulation and Validation

18. NORTH AMERICA CLOUD SERVICES MARKET, BY END USER
18.1. Chapter Overview
18.2. Key Assumptions and Methodology

18.3. North America Pharma Cloud Services Market: Distribution by End User
18.3.1. North America Pharma Cloud Services Market for Pharmaceutical and Life Sciences Companies, Historical Trends (since 2021) and Forecasted Estimates (till 2035)
18.3.2. North America Pharma Cloud Services Market for CROs, Historical Trends (since 2021) and Forecasted Estimates (till 2035)
18.3.3. North America Pharma Cloud Services Market for Others, Historical Trends (since 2021) and Forecasted Estimates (till 2035)

18.4. Data Triangulation and Validation

19. CONCLUDING REMARKS

20. EXECUTIVE INSIGHTS

21. APPENDIX I: TABULATED DATA

22. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS